Skip to main content
NCBI home page
Journal of Virology logoLink to Journal of Virology
. 1997 Jun;71(6):4707–4716. doi: 10.1128/jvi.71.6.4707-4716.1997

RevM10-expressing T cells derived in vivo from transduced human hematopoietic stem-progenitor cells inhibit human immunodeficiency virus replication.

M L Bonyhadi 1, K Moss 1, A Voytovich 1, J Auten 1, C Kalfoglou 1, I Plavec 1, S Forestell 1, L Su 1, E Böhnlein 1, H Kaneshima 1
PMCID: PMC191692  PMID: 9151864

Abstract

A key feature of the pathogenesis of human immunodeficiency virus type 1 (HIV-1) infection is the gradual loss of CD4-positive T cells. A number of gene therapy strategies have been designed with the intent of inhibiting HIV replication in mature T cells. As T cells are products of hematolymphoid differentiation, insertion of antiviral genes into hematopoietic stem cells could serve as a vehicle to confer long-term protection in progeny T cells derived from transduced stem cells. One such "cellular immunization" strategy utilizes the gene coding for the HIV-1 rev trans-dominant mutant protein RevM10 which has been demonstrated to inhibit HIV-1 replication in T-cell lines and in primary T cells. In this study, we used a Moloney murine leukemia virus-based retrovirus encoding a bicistronic message coexpressing RevM10 and the murine CD8-alpha' chain (Lyt2). This vector allows rapid selection of transgene-expressing cells as well as quantitation of transgene expression. We demonstrate that RevM10-transduced CD34-enriched hematopoietic progenitor-stem cells (HPSC) isolated from human umbilical cord blood or from granulocyte colony-stimulating factor-mobilized peripheral blood can give rise to mature thymocytes in the SCID-hu thymus/liver mouse model. The phenotypic distribution of HPSC-derived thymocytes is normal, and expression of the transgene can be detected by flow cytometric analysis. Moreover, we demonstrate that RevM10 can inhibit HIV replication in T cells derived from transduced HPSC after expansion in vitro. This is the first demonstration of anti-HIV efficacy in T cells derived from transduced human HPSC.

Full Text

The Full Text of this article is available as a PDF (369.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aldrovandi G. M., Feuer G., Gao L., Jamieson B., Kristeva M., Chen I. S., Zack J. A. The SCID-hu mouse as a model for HIV-1 infection. Nature. 1993 Jun 24;363(6431):732–736. doi: 10.1038/363732a0. [DOI] [PubMed] [Google Scholar]
  2. Bahnson A. B., Dunigan J. T., Baysal B. E., Mohney T., Atchison R. W., Nimgaonkar M. T., Ball E. D., Barranger J. A. Centrifugal enhancement of retroviral mediated gene transfer. J Virol Methods. 1995 Aug;54(2-3):131–143. doi: 10.1016/0166-0934(95)00035-s. [DOI] [PubMed] [Google Scholar]
  3. Bevec D., Dobrovnik M., Hauber J., Böhnlein E. Inhibition of human immunodeficiency virus type 1 replication in human T cells by retroviral-mediated gene transfer of a dominant-negative Rev trans-activator. Proc Natl Acad Sci U S A. 1992 Oct 15;89(20):9870–9874. doi: 10.1073/pnas.89.20.9870. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bodine D. M., Moritz T., Donahue R. E., Luskey B. D., Kessler S. W., Martin D. I., Orkin S. H., Nienhuis A. W., Williams D. A. Long-term in vivo expression of a murine adenosine deaminase gene in rhesus monkey hematopoietic cells of multiple lineages after retroviral mediated gene transfer into CD34+ bone marrow cells. Blood. 1993 Oct 1;82(7):1975–1980. [PubMed] [Google Scholar]
  5. Bonyhadi M. L., Rabin L., Salimi S., Brown D. A., Kosek J., McCune J. M., Kaneshima H. HIV induces thymus depletion in vivo. Nature. 1993 Jun 24;363(6431):728–732. doi: 10.1038/363728a0. [DOI] [PubMed] [Google Scholar]
  6. Bordignon C., Notarangelo L. D., Nobili N., Ferrari G., Casorati G., Panina P., Mazzolari E., Maggioni D., Rossi C., Servida P. Gene therapy in peripheral blood lymphocytes and bone marrow for ADA- immunodeficient patients. Science. 1995 Oct 20;270(5235):470–475. doi: 10.1126/science.270.5235.470. [DOI] [PubMed] [Google Scholar]
  7. Bridges S. H., Sarver N. Gene therapy and immune restoration for HIV disease. Lancet. 1995 Feb 18;345(8947):427–432. doi: 10.1016/s0140-6736(95)90407-7. [DOI] [PubMed] [Google Scholar]
  8. Challita P. M., Kohn D. B. Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo. Proc Natl Acad Sci U S A. 1994 Mar 29;91(7):2567–2571. doi: 10.1073/pnas.91.7.2567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Champseix C., Maréchal V., Khazaal I., Schwartz O., Fournier S., Schlegel N., Dranoff G., Danos O., Blot P., Vilmer E. A cell surface marker gene transferred with a retroviral vector into CD34+ cord blood cells is expressed by their T-cell progeny in the SCID-hu thymus. Blood. 1996 Jul 1;88(1):107–113. [PubMed] [Google Scholar]
  10. Conneally E., Bardy P., Eaves C. J., Thomas T., Chappel S., Shpall E. J., Humphries R. K. Rapid and efficient selection of human hematopoietic cells expressing murine heat-stable antigen as an indicator of retroviral-mediated gene transfer. Blood. 1996 Jan 15;87(2):456–464. [PubMed] [Google Scholar]
  11. DiGiusto D. L., Lee R., Moon J., Moss K., O'Toole T., Voytovich A., Webster D., Mule J. J. Hematopoietic potential of cryopreserved and ex vivo manipulated umbilical cord blood progenitor cells evaluated in vitro and in vivo. Blood. 1996 Feb 15;87(4):1261–1271. [PubMed] [Google Scholar]
  12. Dunbar C. E., Cottler-Fox M., O'Shaughnessy J. A., Doren S., Carter C., Berenson R., Brown S., Moen R. C., Greenblatt J., Stewart F. M. Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation. Blood. 1995 Jun 1;85(11):3048–3057. [PubMed] [Google Scholar]
  13. Embretson J., Zupancic M., Ribas J. L., Burke A., Racz P., Tenner-Racz K., Haase A. T. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature. 1993 Mar 25;362(6418):359–362. doi: 10.1038/362359a0. [DOI] [PubMed] [Google Scholar]
  14. Escaich S., Kalfoglou C., Plavec I., Kaushal S., Mosca J. D., Böhnlein E. RevM10-mediated inhibition of HIV-1 replication in chronically infected T cells. Hum Gene Ther. 1995 May;6(5):625–634. doi: 10.1089/hum.1995.6.5-625. [DOI] [PubMed] [Google Scholar]
  15. Fauci A. S. Multifactorial nature of human immunodeficiency virus disease: implications for therapy. Science. 1993 Nov 12;262(5136):1011–1018. doi: 10.1126/science.8235617. [DOI] [PubMed] [Google Scholar]
  16. Forestell S. P., Böhnlein E., Rigg R. J. Retroviral end-point titer is not predictive of gene transfer efficiency: implications for vector production. Gene Ther. 1995 Dec;2(10):723–730. [PubMed] [Google Scholar]
  17. Fox B. A., Woffendin C., Yang Z. Y., San H., Ranga U., Gordon D., Osterholzer J., Nabel G. J. Genetic modification of human peripheral blood lymphocytes with a transdominant negative form of Rev: safety and toxicity. Hum Gene Ther. 1995 Aug;6(8):997–1004. doi: 10.1089/hum.1995.6.8-997. [DOI] [PubMed] [Google Scholar]
  18. Haapala D. K., Robey W. G., Oroszlan S. D., Tsai W. P. Isolation from cats of an endogenous type C virus with a novel envelope glycoprotein. J Virol. 1985 Mar;53(3):827–833. doi: 10.1128/jvi.53.3.827-833.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Harper M. E., Marselle L. M., Gallo R. C., Wong-Staal F. Detection of lymphocytes expressing human T-lymphotropic virus type III in lymph nodes and peripheral blood from infected individuals by in situ hybridization. Proc Natl Acad Sci U S A. 1986 Feb;83(3):772–776. doi: 10.1073/pnas.83.3.772. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Ho D. D., Rota T. R., Hirsch M. S. Infection of monocyte/macrophages by human T lymphotropic virus type III. J Clin Invest. 1986 May;77(5):1712–1715. doi: 10.1172/JCI112491. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Jang S. K., Davies M. V., Kaufman R. J., Wimmer E. Initiation of protein synthesis by internal entry of ribosomes into the 5' nontranslated region of encephalomyocarditis virus RNA in vivo. J Virol. 1989 Apr;63(4):1651–1660. doi: 10.1128/jvi.63.4.1651-1660.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Kohn D. B., Weinberg K. I., Nolta J. A., Heiss L. N., Lenarsky C., Crooks G. M., Hanley M. E., Annett G., Brooks J. S., el-Khoureiy A. Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency. Nat Med. 1995 Oct;1(10):1017–1023. doi: 10.1038/nm1095-1017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Macatonia S. E., Lau R., Patterson S., Pinching A. J., Knight S. C. Dendritic cell infection, depletion and dysfunction in HIV-infected individuals. Immunology. 1990 Sep;71(1):38–45. [PMC free article] [PubMed] [Google Scholar]
  24. Malim M. H., Böhnlein S., Hauber J., Cullen B. R. Functional dissection of the HIV-1 Rev trans-activator--derivation of a trans-dominant repressor of Rev function. Cell. 1989 Jul 14;58(1):205–214. doi: 10.1016/0092-8674(89)90416-9. [DOI] [PubMed] [Google Scholar]
  25. Malim M. H., Freimuth W. W., Liu J., Boyle T. J., Lyerly H. K., Cullen B. R., Nabel G. J. Stable expression of transdominant Rev protein in human T cells inhibits human immunodeficiency virus replication. J Exp Med. 1992 Oct 1;176(4):1197–1201. doi: 10.1084/jem.176.4.1197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. McCune J. M., Namikawa R., Kaneshima H., Shultz L. D., Lieberman M., Weissman I. L. The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science. 1988 Sep 23;241(4873):1632–1639. doi: 10.1126/science.241.4873.1632. [DOI] [PubMed] [Google Scholar]
  27. McCune J., Kaneshima H., Krowka J., Namikawa R., Outzen H., Peault B., Rabin L., Shih C. C., Yee E., Lieberman M. The SCID-hu mouse: a small animal model for HIV infection and pathogenesis. Annu Rev Immunol. 1991;9:399–429. doi: 10.1146/annurev.iy.09.040191.002151. [DOI] [PubMed] [Google Scholar]
  28. McIlroy D., Autran B., Cheynier R., Wain-Hobson S., Clauvel J. P., Oksenhendler E., Debré P., Hosmalin A. Infection frequency of dendritic cells and CD4+ T lymphocytes in spleens of human immunodeficiency virus-positive patients. J Virol. 1995 Aug;69(8):4737–4745. doi: 10.1128/jvi.69.8.4737-4745.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Migita M., Medin J. A., Pawliuk R., Jacobson S., Nagle J. W., Anderson S., Amiri M., Humphries R. K., Karlsson S. Selection of transduced CD34+ progenitors and enzymatic correction of cells from Gaucher patients, with bicistronic vectors. Proc Natl Acad Sci U S A. 1995 Dec 19;92(26):12075–12079. doi: 10.1073/pnas.92.26.12075. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Murray L., Chen B., Galy A., Chen S., Tushinski R., Uchida N., Negrin R., Tricot G., Jagannath S., Vesole D. Enrichment of human hematopoietic stem cell activity in the CD34+Thy-1+Lin- subpopulation from mobilized peripheral blood. Blood. 1995 Jan 15;85(2):368–378. [PubMed] [Google Scholar]
  31. Namikawa R., Weilbaecher K. N., Kaneshima H., Yee E. J., McCune J. M. Long-term human hematopoiesis in the SCID-hu mouse. J Exp Med. 1990 Oct 1;172(4):1055–1063. doi: 10.1084/jem.172.4.1055. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Nolta J. A., Dao M. A., Wells S., Smogorzewska E. M., Kohn D. B. Transduction of pluripotent human hematopoietic stem cells demonstrated by clonal analysis after engraftment in immune-deficient mice. Proc Natl Acad Sci U S A. 1996 Mar 19;93(6):2414–2419. doi: 10.1073/pnas.93.6.2414. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Plavec I., Voytovich A., Moss K., Webster D., Hanley M. B., Escaich S., Ho K. E., Böhnlein E., DiGiusto D. L. Sustained retroviral gene marking and expression in lymphoid and myeloid cells derived from transduced hematopoietic progenitor cells. Gene Ther. 1996 Aug;3(8):717–724. [PubMed] [Google Scholar]
  34. Ragheb J. A., Bressler P., Daucher M., Chiang L., Chuah M. K., VandenDriessche T., Morgan R. A. Analysis of trans-dominant mutants of the HIV type 1 Rev protein for their ability to inhibit Rev function, HIV type 1 replication, and their use as anti-HIV gene therapeutics. AIDS Res Hum Retroviruses. 1995 Nov;11(11):1343–1353. doi: 10.1089/aid.1995.11.1343. [DOI] [PubMed] [Google Scholar]
  35. Riddell S. R., Elliott M., Lewinsohn D. A., Gilbert M. J., Wilson L., Manley S. A., Lupton S. D., Overell R. W., Reynolds T. C., Corey L. T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients. Nat Med. 1996 Feb;2(2):216–223. doi: 10.1038/nm0296-216. [DOI] [PubMed] [Google Scholar]
  36. Rigg R. J., Chen J., Dando J. S., Forestell S. P., Plavec I., Böhnlein E. A novel human amphotropic packaging cell line: high titer, complement resistance, and improved safety. Virology. 1996 Apr 1;218(1):290–295. doi: 10.1006/viro.1996.0194. [DOI] [PubMed] [Google Scholar]
  37. Rigg R. J., Dando J. S., Escaich S., Plavec I., Böhnlein E. Detection of intracellular HIV-1 Rev protein by flow cytometry. J Immunol Methods. 1995 Dec 27;188(2):187–195. doi: 10.1016/0022-1759(95)00237-5. [DOI] [PubMed] [Google Scholar]
  38. Rosenzweig M., Clark D. P., Gaulton G. N. Selective thymocyte depletion in neonatal HIV-1 thymic infection. AIDS. 1993 Dec;7(12):1601–1605. doi: 10.1097/00002030-199312000-00009. [DOI] [PubMed] [Google Scholar]
  39. Su L., Kaneshima H., Bonyhadi M., Salimi S., Kraft D., Rabin L., McCune J. M. HIV-1-induced thymocyte depletion is associated with indirect cytopathogenicity and infection of progenitor cells in vivo. Immunity. 1995 Jan;2(1):25–36. doi: 10.1016/1074-7613(95)90076-4. [DOI] [PubMed] [Google Scholar]
  40. Tagawa M., Nakauchi H., Herzenberg L. A., Nolan G. P. Formal proof that different-size Lyt-2 polypeptides arise from differential splicing and post-transcriptional regulation. Proc Natl Acad Sci U S A. 1986 May;83(10):3422–3426. doi: 10.1073/pnas.83.10.3422. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Vandekerckhove B. A., Namikawa R., Bacchetta R., Roncarolo M. G. Human hematopoietic cells and thymic epithelial cells induce tolerance via different mechanisms in the SCID-hu mouse thymus. J Exp Med. 1992 Apr 1;175(4):1033–1043. doi: 10.1084/jem.175.4.1033. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Woffendin C., Ranga U., Yang Z., Xu L., Nabel G. J. Expression of a protective gene-prolongs survival of T cells in human immunodeficiency virus-infected patients. Proc Natl Acad Sci U S A. 1996 Apr 2;93(7):2889–2894. doi: 10.1073/pnas.93.7.2889. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Zucker-Franklin D., Cao Y. Z. Megakaryocytes of human immunodeficiency virus-infected individuals express viral RNA. Proc Natl Acad Sci U S A. 1989 Jul;86(14):5595–5599. doi: 10.1073/pnas.86.14.5595. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES